{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-089839","form_type":"8-K","ticker":"SUPN","cik":"0001356576","company_name":"SUPERNUS PHARMACEUTICALS, INC.","filed_at":"2026-08-03T21:00:36+00:00","discovered_at":"2026-08-03T21:02:03.823852+00:00","generated_at":"2026-08-03T21:02:12.147219+00:00","sec_items":["8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Supernus and Indivior announce all-stock merger of equals to create CNS-focused biopharma company","bullets":["All-stock merger of equals between Supernus and Indivior; combined company to have four established CNS/behavioral health franchises.","Jack Khattar (Supernus CEO) to serve as CEO of combined company; transaction expected to close in Q4 2026.","Combined portfolio includes SUBLOCADE (opioid use disorder), Qelbree (ADHD), Zurzuvae (postpartum depression), Onapgo and GOCOVRI (Parkinson's).","Merger intended to create financial strength and flexibility for business development; integration planning to be structured."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-089839","json":"https://secwatch.observer/filing/0001104659-26-089839.json","markdown":"https://secwatch.observer/filing/0001104659-26-089839.md","text":"https://secwatch.observer/filing/0001104659-26-089839.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1356576/000110465926089839/0001104659-26-089839-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1356576/000110465926089839/tm2622009d7_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-03T21:02:12.147219+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}